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ABSTRACT  Treatment  of  mouse  lymphoma  $49  cells  with  D,L-~x-difluoromethylornithine 
(DFMO),  an  inhibitor  of  ornithine  decarboxylase,  depleted  cellular  polyamine  levels  and 
stopped cell  growth. The cells were arrested  predominantly in G1. Thus, polyamine depletion 
may  lead  to a regulatory growth  arrest  in $49 cells. We tested  two hypotheses regarding  the 
relationship of growth arrest mediated by polyamine limitation to that mediated by cyclic AMP 
(cAMP).  The  hypothesis that cAMP-induced  arrest  results  from  polyamine  depletion  is  not 
tenable,  because the arrest could  not be reversed  by addition of exogenous polyamines, and 
because  cellular  polyamine  levels  do  not drop  in  dibuturyl  cyclic  AMP  (Bt2cAMP)-arrested 
cells.  The  hypothesis that  polyamine-mediated  growth  arrest  is effected  via  modulation  of 
cAMP  levels  or  cAMP-dependent  protein  kinase  activity was  also  shown  to  be  incorrect, 
because a $49 variant deficient in cAMP-dependent protein kinase was arrested by DFMO. The 
activities of the polyamine-synthesizing enzymes  ornithine decarboxylase  (ODC)  and S-aden- 
osyl  methionine decarboxylase  (SAMD)  are both  reduced  in  Bt2cAMP-treated cells  to about 
10% of that in control  populations, as shown previously. DFMO diminishes ODC activity and 
augments  SAMD activity in both  untreated  and  Bt2cAMP-treated  cells,  leading to polyamine 
depletion in both cases. 
Numerous  studies  indicate  that  the  polyamines  putrescine, 
spermidine,  and  spermine  influence  cell  proliferation.  Two 
sorts of evidence support this: first,  polyamine levels and the 
activities of their synthesizing enzymes, ornithine decarboxyl- 
ase  (ODC)  and  S-adenosyl  methionine  decarboxylase 
(SAMD), vary with the proliferative state of the cell (1),  and 
second, pharmacologically induced depletion of cellular poly- 
amines  leads  to reduced cellular proliferation  (2-11).  Polya- 
mines may simply be necessary constituents  for proliferating 
cells or they may be regulatory molecules, signaling the cells to 
initiate or cease proliferation. 
We ask here whether polyamines are necessary for growth 
of mouse lymphoma $49 cells,  whether they behave as regu- 
latory molecules with respect to cell cycle specificity of arrest, 
and finally whether causal connections exist among regulatory 
systems controling cyclic AMP (cAMP), polyamines, and cell 
growth. 
ODC is the enzyme responsible for synthesis of putrescine 
from ornithine.  Spermidine and spermine are generated from 
putrescine  by addition of one and two aminopropyl groups, 
respectively.  SAMD generates  the aminopropyl donor mole- 
cules for this reaction and is the rate-limiting enzyme for the 
synthesis of these higher polyamines. We show here that treat- 
ment of $49 cells with a-difluoromethylornithine (DFMO), an 
enzyme-activated irreversible inhibitor of ODC, depletes cells 
of polyamines and halts cell proliferation. Because regulators 
of cell growth act primarily to change the duration of the G1 
phase  of the  cell  cycle (12)  we  assume  that  a  G1  arrest  is 
suggestive  of a  regulatory  growth  arrest.  S49  cells  show  a 
predominantly GI phase arrest with  DFMO treatment.  This 
indicates that in these cells polyamines are potentially regula- 
tory molecules. Previous work has demonstrated that treatment 
of $49 cells with biologically active cAMP analogues such as 
dibutyryl cAMP (Bt2cAMP) arrests cells in the GE phase (13) 
and extinguishes the activities of ODC and of SAMD (14,  15). 
Both responses are mediated via the cAMP-dependent protein 
kinase, as both are abolished in $49 mutant cells devoid of that 
kinase (13-15). 
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cAMP levels rise, cAMP kinase is activated, ODC and SAMD 
are inactivated, polyamine levels decrease, and Gt arrest results 
from  the  depletion  of polyamines.  We  show  here  that  this 
model is wrong. A second model that connects polyamines and 
cAMP  may  be  considered:  DFMO  reduces  ODC  activity, 
polyamine levels decrease, this leads to increased cAMP levels, 
cAMP kinase is activated, and G1 arrest ensues. We show that 
this model also is incorrect and conclude therefore that cAMP 
and  polyamines  influence  cell  growth  through  mechanisms 
whose initial steps, at least, are distinct. 
MATERIALS  AND  METHODS 
Data in all figures and tables are from representative experiments, each of which 
was repeated multiple times. 
Cell Culture:  In these studies we have used mutant $49 ceils (deathless 
variant, clone 21 I. 1.2), which have all the growth regulatory  responses to elevated 
cAMP levels of wild type ceils but which, unlike wild type $49 cens, do not die 
in response to elevated cAMP (14,  16). This is necessary to distinguish cAMP's 
effects on polyamines due to growth arrest from those due to cellular death. Ceils 
were maintained in Dulbecco's modified Eagle's (DME) medium, 3 gm/l glucose, 
and 10 percent heat-inactivated horse serum at cell densities from 10  ~ to 106 per 
ml. Cell numbers were determined with an electronic particle counter (Coulter 
model ZBI, Coulter Electronics Inc~, Hialeah, FL). 
Enzyme Assays:  ODC and SAMD assays were performed as described 
(14)  except  that  the  released  ~4COe was  trapped  on  a  piece  of filter  paper 
(Whatman 3 mm, Whatman Inc.. Paper Div., Clifton, NJ) spotted with  10 ,td l 
M  hyamine hydroxide. In both assays enzyme activities were linear with time 
and proportional to  the amount  of protein added. Cellular lysates for enzyme 
assays were prepared from cells washed once with cold phosphate-buffered saline 
(PBS) and resuspended in  hypotonic buffer (5  mM  Tris  HCI  pH  7.5, 2  mM 
dithiothreitol) at a concentration of 4 x  l07 cells/ml. Cells were quick-frozen in 
a dry ice-ethanol bath and stored in liquid nitrogen. Cells were lysed by a  total 
of three cycles of freeze-thawing. Homogenates were centrifuged at 100,000 g for 
60 min and the supernatants assayed. In some cases the superuatants were again 
stored in liquid nitrogen until assayed. 
Polyamine Measurements:  Cells were washed one time with PBS 
and centrifuged. The PBS was decanted and the tubes were wiped to remove all 
excess solution. Cell pellets were resuspended in 8% fresh 5-sulfosalicycllc acid 
(250 #l/pellet  or 3.5  x  l07 cells/250 #l, both  methods gave the same results). 
Polyamine levels were measured as described (9). 
Flow Cytometry:  The distribution of cell populations in the cell cycle 
was determined by staining ethanol-fixed cells with chromomycin and analyzing 
them with a  flow cytometer (FCM) at the Lawrence Livermore Laboratory as 
described (17). 
Experimental Design:  Cells  were fed by a threefold dilution, allowed 
to grow 1 d, and again fed, this time by fivefold dilution with medium containing 
the appropriate drug. Polyamine levels, cell numbers, and FCM distribution were 
measured at indicated times fol/owmg drug addition. 
RESULTS 
Effects of Polyamine Depletion on Cell  Growth 
Treatment of $49 cells with DFMO stopped cell growth (Fig. 
1).  This  effect  was  completely  prevented  by  adding  10  #M 
putrescine along with the drug. Putrescine's ability to abolish 
DFMO's growth inhibitory effect indicates that the inhibition 
is  due  to  polyamine  depletion  and  not  to  some  nonspecific 
effect of the drug. Cells arrested by 3 d of drug treatment could 
be'made  to resume growth by  refeeding  with  fresh  medium 
containing putrescine.  DFMO  treatment of $49 cells was not 
very toxic; it reduced their cloning efficiency in medium con- 
taining  putrescine  to 76%  in 2  d  and  70%  in 3  d,  relative to 
control  cells.  Refeeding  with  fresh  medium  alone  did  not 
reverse  the  growth  arrest.  This  result  further  supports  the 
specificity of DFMO  by ruling out the possibility that putres- 
cine abolishes the effect of DFMO by reducing its uptake into 
cells. 
The  kinetics of DFMO  arrest were the same regardless of 
whether cultures were treated at initial cell densities as low as 
104 per ml or as high as 106 per ml (data not shown). Initial cell 
densities lower than 104 per ml could not be tested, as $49 cells 
do not grow exponentially under these conditions. Therefore, 
we have no evidence for or against the hypothesis that arrest 
is mediated by a factor released by DFMO-treated $49 cells, as 
has been demonstrated for CHO cells (18). 
Measurement of intracellular levels of polyamines (Table I) 
showed that DFMO treatment led to a depletion of spermidine. 
Putrescine  addition  replenished  spermidine pools.  Putrescine 
levels in $49  cells were too low to be reliably measured with 
the number of cells used, except when cells were treated with 
exogenous  putrescine.  In  those  experiments  in  which  the 
amount of endogenous putrescine could be measured, its mod- 
ulation  paralleled  that  of spermidine.  These  data  imply that 
depletion of spermidine and  perhaps putrescine leads  to ces- 
sation of cell proliferation. 
Cell Cycle Specificity  of DFMO  Arrest 
To determine the cell cycle specificity of DFMO  arrest, we 
analyzed control and  DFMO-treated  cells by flow cytometry 
(FCM), a procedure that measures DNA content per cell and 
thus determines the distribution of the cell population among 
the  Gx,  S,  and  G2  +  M  phases  of the  growth  cycle.  FCM 
measurements are shown of cells treated with DFMO  for 24, 
48,  and  72  h,  and  of untreated  and  DFMO  plus putrescine- 
treated cells at 24 h  (Fig. 2). FCMs  of untreated control ceils 
and DFMO plus putrescine-treated cells at 48 and 72 h are not 
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FIGUR[  I  Effect of  DFMO  on  cell  growth  and  its  reversal  by  pu- 
trescine. $49 cells were grown without drugs  (O) or in  the presence 
of  0.1  mM  DFMO  (&),  DFMO  plus  putrescine  (O),  or  DFMO 
followed by 74 h with medium alone (1:3) or with medium containing 
putrescine  (I),  as  described  in  Materials  and  Methods.  After  re- 
moval from medium containing  DFMO, $49 cells were resuspended 
at 3 x  10  s cells/ml  and treated with 0.1  mM  DFMO or with  10/tM 
putrescine as indicated. Data are summarized from two experiments. 
For  reversal  of  DFMO  treatment,  $49  cells  were  counted  with  a 
hemocytometer. 
TABLE  I 
Measurement of Intracellular Levels  of Polyamines 
Treatment  Spermidine  Spermine 
nm/10 e cells 
None  0.69  0.84 
DFMO  0.017  0.30 
DFMO +  Putrescine  1.20  0.59 
Effect of DFMO and  putrescine  on cellular polyamine pools.  $49 cells were 
treated as in  Fig. 1 and harvested for polyamine measurements after 49 h of 
drug  treatment. 
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FIGURE  2  Cell cycle distribution of DFMO treated cells. Cells were treated as in Fig. 1 and FCM measurements taken at 24, 48, and 
72 h. FCM measurements of DFMO-treated cells are shown at all time points. FCM measurements of untreated and DFMO plus 
putrescine-treated cells are shown at 24 h only, as discussed in the text. Data are displayed as fluorescence per cell on the abscissa 
and as cell number on the ordinate, both in arbitrary units. 
included as exponentially growing cultures have reached very 
high cell densities by 48  h.  When cells were plated at lower 
densities, they did not show FCM pertubations after 48 and 72 
h but did when similarly high cell densities were reached (data 
not  shown).  In  these  experiments,  DFMO-  and  Bt2cAMP- 
arrested cells at no  time reached cell densities at which un- 
treated cells show FCM pertubations. The fraction of cells in 
the G1 phase was slightly increased after 1 d of treatment with 
DFMO; after 3 d the effect was pronounced. This implies that 
the  growth  inhibition  produced  by  DFMO  results  from  a 
prolongation of G1 relative to other phases of the cell cycle. 
Such a Gl-specific growth arrest is consistent with a potentially 
regulatory role for polyamines. DFMO's effect on cell cycle 
distribution was completely prevented by the addition of 10 
/~M exogenous putrescine. Treatment of cells with DFMO in 
medium containing dialyzed horse serum rather than unmod- 
ified horse serum changed neither the kinetics nor the cell cycle 
specificity of arrest (data not shown). Therefore, the amount of 
polyamines in  the  horse  serum  is  insufficient  to  affect  the 
response. 
Interrelation between cAMP and Polyamine 
Growth Regulatory Systems in $49  Cells 
We tested in a number of ways the hypothesis that Bt2cAMP- 
mediated arrest of $49 ceils occurs via depletion of intracellular 
polyamines. This hypothesis predicts that the arrest should be 
reversed by replenishing polyamine pools. There was no effect 
on the kinetics of Bt2cAMP arrest when exogenous putrescine 
was added at a concentration that completely prevents growth 
inhibition by DFMO (Fig. 3). Nor did the addition of putres- 
cine  have  any  effect on  the  FCM  distribution of Bt2cAMP 
arrested cells (Fig. 4).  In order to  show  that  the exogenous 
putrescine entered the cells and effectively replenished pools, 
we measured intracellular polyamines. Fig. 5  shows that ex- 
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FIGUR[ 3  EffeCt  of putrescine and Bt2cAMP on growth of $49 cells. 
$49 cells were untreated (O) or treated with either 0.5 mM Bt~cAMP 
(ll)  or  Bt2cAMP  plus  10 #M  putrescine  ([]])  and  cell  number was 
measured. 
ogenous  putrescine  entered  Bt2cAMP-treated ceils  and  was 
metabolized to  spermidine;  spermidine  pools  were  elevated 
above control levels in cells treated with both putrescine and 
Bt2cAMP. Putrescine pools were also elevated to easily mea- 
surable  levels,  i.e.,  above  control  levels  (data  not  shown). 
Therefore,  Bt2cAMP  arrest  is  not  reversed  by  elevation of 
polyamine pools. This implies that the arrest is not mediated 
via depletion of polyamine pools. 
Intracellular polyamine pools were measured as a  function 
of time  in  untreated  cultures  and  in  cultures  treated  with 
DFMO,  DFMO  plus  putrescine,  Bt2cAMP,  Bt2cAMP  plus 
putrescine, and Bt2cAMP followed 24 h later with DFMO (Fig. 
5).  All cultures were refed with fresh medium at the time of 
drug addition. As previously discussed, putrescine levels were 
too low to measure reliably but appeared to vary directly with 
spermidine  levels (data  not  shown).  Spermine  pools  stayed 
relatively constant under all conditions (data not shown),  as 
reported for other cell types (5-10,  18,  19). Spermidine pools 
rose about twofold in untreated control cells during the 50-h t~ 
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FIGURE  4  Effect  of  putrescine  on  the  celt  cycle  distribution  of 
Bt2cAMP-arrested  $49 cells.  $49 cells were treated  as in  Fig.  3  and 
FCM measurements taken at 26 h.  Data are displayed as in  Fig.  2. 
course of the experiment, rose even more rapidly in putrescine- 
treated  cells,  fell precipitously in  DFMO-treated  cells,  and 
remained constant in Bt2cAMP-treated cells. Since polyamine 
levels do  not  drop  in  Bt2cAMP-treated cells we  can  again 
conclude that the arrest is not mediated through modulation of 
polyamine levels. This  result  was  unexpected  as  ODC  and 
SAMD activities drop to about  10% of control values under 
these conditions. Clearly, that reduced activity is sufficient to 
maintain polyamine pools during growth arrest. Further treat- 
ment of Bt2cAMP-treated ceils with DFMO at 24 h  led to a 
decrease in  spermidine levels, indicating that  the  remaining 
ODC activity can be pharmacologically  inhibited and is indeed 
required  to  maintain  polyamine  pools.  Similar experiments 
that included longer time courses showed that DFMO contin- 
ues to deplete spermidine levels in Bt2cAMP-treated cells to 
10%  of values in cultures treated with Bt2cAMP alone (data 
not shown). 
Fig. 6  shows the activities of ODC  and  SAMD under the 
same conditions as used in the experiments shown in Fig. 5. 
Cultures refed with medium alone exhibited increases in both 
ODC and SAMD activities. This stimulation accounts for the 
increase in spermidine pools seen in Fig. 5. DFMO treatment 
of cells rapidly extinguished  ODC  activity and  produced  a 
slight augmentation of SAMD activity. This enhancement of 
SAMD  activity was  more  prominent  in  other  experiments. 
DFMO  induction of SAMD has been reported in other cell 
systems, and it was suggested that SAMD induction was stim- 
ulated by reduced polyamine levels (7,  11, 20-23).  Bt2cAMP 
treatment  of ceils  led  to  a  small  early  rise  followed  by  a 
precipitous drop in both ODC and SAMD activities, as previ- 
ously reported (14); each fell to -10% of its initial value by 10 
h. Subsequent treatment of Bt2cAMP-treated cells with DFMO 
dropped ODC  activity further  and  induced  SAMD activity. 
The  induction of SAMD was  abolished by the addition of 
putrescine along with DFMO, suggesting that the reduction of 
polyamine pools is the signal for the induction. 
Studies in this and in other laboratories have shown that the 
kin- $49 cell mutant is devoid of measurable cAMP-dependent 
protein  kinase  activity  and  lacks  all  responses  to  elevated 
cAMP levels (14, 24, 25). We tested the hypothesis that DFMO 
arrest is modulated through  the  cAMP kinase by using this 
mutant. Deathless (kin  +  ) and kin- cells were treated in parallel 
with DFMO, and cell growth and  FCM measurements were 
made.  Both cell types were  arrested, and  the kinetics of the 
arrest were  identical (data not  shown).  FCM  measurements 
made 72 h  after treatment with DFMO were identical in the 
two cell types, indicating that the change in cell cycle distri- 
bution of the arrested cells is also not mediated via the cAMP 
kinase (Fig. 7).  Therefore the arrest and change in cell cycle 
distribution  induced  by  DFMO  cannot  be  modulated  via 
cAMP kinase, as the arrest and redistribution occur identically 
in cells having or lacking that kinase. 
DISCUSSION 
The  major  conclusions  we  draw  from  these  data  are  that 
polyamine depletion arrests the growth of $49  cells, that the 
cell cycle specificity  of the arrest is characteristic of a regulatory 
response, and that this arrest is dissociable from cAMP-medi- 
ated arrest. 
We have shown that DFMO-mediated arrest is due to poly- 
amine  depletion.  It  is  possible that  the  arrest  is  due  to  a 
secondary effect of polyamine depletion rather than  being a 
direct response to lowered polyamine levels. For example, the 
increased SAMD activity accompanying polyamine depletion 
could lead to decreased levels of S-adenosylmethionine and/or 
increased levels of decarboxylated S-adenosylmethionine. This 
possibility has been discussed in other reports (26, 27). 
$49 cells arrested by DFMO are predominantly in G1. We 
recognize that this suggests a  Gl-specific block but does not 
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FIGURE  5  Spermidine  levels in  $49 cells treated with  various com- 
binations of DFMO,  putrescine, and Bt2cAMP.  Cells were treated as 
described  in  Materials  and  Methods  and  harvested  for  polyamine 
measurements.  Drug  concentrations  are the  same as those  in  pre- 
vious  figures.  Control  (O),  DFMO  (&),  Bt2cAMP  (ll  L  DFMO  plus 
putrescine (A), Bt2cAMP plus putrescine (FI),  and Bt2cAMP followed 
at 24 h with  DEMO  (~11.). 
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FIGURE  6  Time course of ODC  and SAMD activities in $49 cells treated with various combinations of DFMO,  putrescine, and 
Bt2cAMP. S49 cells were treated with drugs, lysates prepared, and assayed for ODC and SAMD. Control (@), DFMO (&), Bt2cAMP 
(111), Bt2cAMP followed at 24 h with DFMO (El), and Bt2cAMP followed at 24 h with DFMO and putrescine (41,). Drug concentrations 
are the same as in previous figures. 
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60 
prove that progression through other phases of the cell cycle is 
unaffected.  Further  studies  are  needed  to  resolve this.  The 
growth inhibition induced by polyamine depletion in $49 cells 
is  neither  so  prompt  nor  so  complete  as  that  induced  by 
activation of cAMP-dependent protein kinase. Whether and, 
if so, under what conditions intracellular depletion of polya- 
mines is of physiologic significance in regulating cell growth 
remains to be established. 
In all cases the activities of polyamine synthetic enzymes are 
consistent with the modulations in polyamine pools. Bt2cAMP 
treatment leads to a coordinate lowering of ODC and SAMD 
activities; the  polyamine pools  are  little perturbed.  DFMO 
lowers ODC and induces SAMD; putrescine levels are reduced, 
and the remaining spermidine is converted to spermine and/or 
other products. This occurs either when cells are treated with 
DFMO  alone  or when  DFMO  treatment  follows Bt2cAMP 
treatment. Thus the ODC activity that remains in Bt2cAMP- 
treated ceils is functional in maintaining polyamine levels. The 
kinetics of modulation of ODC  activity and cell division by 
DFMO and Bt2cAMP do not differ greatly, yet DFMO drast- 
ically reduces spermidine levels, ,whereas spermidine levels are 
little  perturbed  in  Bt2cAMP-treated  cultures.  Therefore, 
Bt2cAMP-treated ceils must maintain their spermidine pools 
largely by reducing SAMD activity, thus reducing the rate of 
conversion of spermidine to spermine, or possibly by reducing 
the  rate of spermidine's metabolic conversion through  other 
pathways,  such  as  oxidation or  acetylation.  It  appears  that 
ODC and SAMD activities are modulated in a way that retains 
normal polyamine levels during BtzcAMP arrest. 
Russell et al. (28) reported polyamine levels, ODC activities, 
and SAMD activities in $49 cells treated with Bt2cAMP. Their 
data differ from ours in that they found that polyamine levels 
had  dropped  in  cells treated  with  Bt2cAMP  for  24  h.  This 
difference may be attributable to the fact that they used wild 
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FIGURE  7  Effect of DFMO on the ceil cycle distribution of kin* and 
kin- $49 cells. Kin- and deathless (kin +) $49 cells were grown with 
and without 0.1 mM DFMO for 72 h and analyzed by FCM. 
type $49 cells, whereas we used the cAMP deathless variant. 
This variant, although identical to the wild type in its growth 
response to DFMO (unpublished) and Bt~cAMP (16), is resist- 
ant to the cytolytic effect of Bt2cAMP. Interpretation of their 
results  is  also  made  difficult by  the  fact  that  their control 
cultures were neither growing exponentially nor maintaining 
stable  ODC  activities during  the  course  of the  experiments 
reported. Our results, however, support and extend their con- 
clusion that, in viable cells, cAMP has little effect on spermi- 
dine pools. 
We have tested two models that connect cAMP- and poly- 
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mediated by lowering polyamine pools,  and second,  that poly- 
amine  arrest  is  mediated  via  cAMP-dependent  kinase.  Both 
models  are  incorrect.  Therefore,  the  initial  steps  for  arrest 
mediated by cAMP  and polyamines are distinct. 
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